| Year |
Citation |
Score |
| 2024 |
Tosoian JJ, Zhang Y, Xiao L, Xie C, Samora NL, Niknafs YS, Chopra Z, Siddiqui J, Zheng H, Herron G, Vaishampayan N, Robinson HS, Arivoli K, Trock BJ, Ross AE, ... ... Feng Z, et al. Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer. Jama Oncology. PMID 38635241 DOI: 10.1001/jamaoncol.2024.0455 |
0.315 |
|
| 2024 |
Liu S, Hawley SJ, Kunder CA, Hsu EC, Shen M, Westphalen L, Auman H, Newcomb LF, Lin DW, Nelson PS, Feng Z, Tretiakova MS, True LD, Vakar-Lopez F, Carroll PR, et al. High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker. Scientific Reports. 14: 486. PMID 38177207 DOI: 10.1038/s41598-023-50215-z |
0.331 |
|
| 2022 |
Ruder S, Gao Y, Ding Y, Bu P, Miles B, De Marzo A, Wheeler T, McKenney JK, Auman H, Fazli L, Simko J, Coll AH, Troyer DA, Carroll PR, Gleave M, ... ... Feng Z, et al. Development and Validation of a Quantitative Reactive Stroma Biomarker (qRS) for Prostate Cancer Prognosis. Human Pathology. PMID 35176252 DOI: 10.1016/j.humpath.2022.01.009 |
0.319 |
|
| 2020 |
Singal AG, Lok AS, Feng Z, Kanwal F, Parikh ND. Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda Clinical Gastroenterology and Hepatology. PMID 32961340 DOI: 10.1016/J.Cgh.2020.09.036 |
0.316 |
|
| 2020 |
Dai JY, Wang X, Wang B, Sun W, Jordahl KM, Kolb S, Nyame YA, Wright JL, Ostrander EA, Feng Z, Stanford JL. DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs. Plos Genetics. 16: e1008667. PMID 32226005 DOI: 10.1371/Journal.Pgen.1008667 |
0.35 |
|
| 2020 |
Wang X, Grasso CS, Jordahl KM, Kolb S, Nyame YA, Wright JL, Ostrander EA, Troyer DA, Lance R, Feng Z, Dai JY, Stanford JL. Copy number alterations are associated with metastatic-lethal progression in prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 32071439 DOI: 10.1038/S41391-020-0212-8 |
0.428 |
|
| 2020 |
Schwartz NR, Matrisian LM, Shrader E, Feng Z, Chari S, Roth JA. The potential cost-effectiveness of a risk-based pancreatic cancer screening strategy in new-onset diabetes. Journal of Clinical Oncology. 38: 7017-7017. DOI: 10.1200/Jco.2020.38.15_Suppl.7017 |
0.356 |
|
| 2019 |
Wang L, Huang Y, Feng Z. Strategies for validating biomarkers using data from a reference set. Biostatistics (Oxford, England). PMID 31420985 DOI: 10.1093/Biostatistics/Kxz031 |
0.309 |
|
| 2019 |
Cheng A, Zhao S, FitzGerald LM, Wright JL, Kolb S, Karnes RJ, Jenkins RB, Davicioni E, Ostrander EA, Feng Z, Fan JB, Dai JY, Stanford JL. A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: Development and validation studies. The Prostate. PMID 31376183 DOI: 10.1002/Pros.23882 |
0.42 |
|
| 2018 |
Borges KA, Dai J, Parikh ND, Schwartz M, Nguyen MH, Roberts LR, Befeler AS, Srivastava S, Rinaudo JA, Feng Z, Marrero JA, Rajender Reddy K. Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's early Detection Research Network. Contemporary Clinical Trials. PMID 30439517 DOI: 10.1016/J.Cct.2018.11.008 |
0.328 |
|
| 2018 |
Yadav D, Park WG, Fogel EL, Li L, Chari ST, Feng Z, Fisher WE, Forsmark CE, Jeon CY, Habtezion A, Hart PA, Hughes SJ, Othman MO, Rinaudo JAS, Pandol SJ, et al. PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas. 47: 1229-1238. PMID 30325862 DOI: 10.1097/Mpa.0000000000001170 |
0.302 |
|
| 2018 |
Serrano J, Andersen DK, Forsmark CE, Pandol SJ, Feng Z, Srivastava S, Rinaudo JAS. Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer: From Concept to Reality. Pancreas. 47: 1208-1212. PMID 30325859 DOI: 10.1097/Mpa.0000000000001167 |
0.311 |
|
| 2018 |
Bantis LE, Feng Z. Comparison of two correlated ROC surfaces at a given pair of true classification rates. Statistics in Medicine. PMID 30010205 DOI: 10.1002/Sim.7894 |
0.335 |
|
| 2018 |
Guida F, Sun N, Bantis LE, Muller DC, Li P, Taguchi A, Dhillon D, Kundnani DL, Patel NJ, Yan Q, Byrnes G, Moons KGM, Tjønneland A, Panico S, ... ... Feng Z, et al. Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins. Jama Oncology. e182078. PMID 30003238 DOI: 10.1001/Jamaoncol.2018.2078 |
0.342 |
|
| 2018 |
Zhao S, Leonardson A, Geybels MS, McDaniel AS, Yu M, Kolb S, Zong H, Carter K, Siddiqui J, Cheng A, Wright JL, Pritchard CC, Lance R, Troyer D, Fan JB, ... ... Feng Z, et al. A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer. The Prostate. PMID 29956356 DOI: 10.1002/Pros.23667 |
0.415 |
|
| 2018 |
Sahoo D, Wei W, Auman H, Hurtado-Coll A, Carroll PR, Fazli L, Gleave ME, Lin DW, Nelson PS, Simko J, Thompson IM, Leach RJ, Troyer DA, True LD, McKenney JK, ... Feng Z, et al. Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer. Oncotarget. 9: 6550-6561. PMID 29464091 DOI: 10.18632/Oncotarget.23973 |
0.4 |
|
| 2018 |
Ankerst DP, Goros M, Tomlins SA, Patil D, Feng Z, Wei JT, Sanda MG, Gelfond J, Thompson IM, Leach RJ, Liss MA. Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator. European Urology Focus. PMID 29422418 DOI: 10.1016/J.Euf.2018.01.010 |
0.31 |
|
| 2018 |
FitzGerald LM, Zhao S, Leonardson A, Geybels MS, Kolb S, Lin DW, Wright JL, Eeles R, Kote-Jarai Z, Govindasami K, Giles GG, Southey MC, Schleutker J, Tammela TL, Sipeky C, ... ... Feng Z, et al. Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases. Prostate Cancer and Prostatic Diseases. PMID 29298992 DOI: 10.1038/S41391-017-0029-2 |
0.401 |
|
| 2017 |
Geybels MS, Fang M, Wright JL, Qu X, Bibikova M, Klotzle B, Fan JB, Feng Z, Ostrander EA, Nelson PS, Stanford JL. PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles. Oncotarget. 8: 84338-84348. PMID 29137428 DOI: 10.18632/Oncotarget.20940 |
0.371 |
|
| 2017 |
Yan Q, Bantis LE, Stanford JL, Feng Z. Combining multiple biomarkers linearly to maximize the partial area under the ROC curve. Statistics in Medicine. PMID 29082535 DOI: 10.1002/Sim.7535 |
0.339 |
|
| 2017 |
Bantis LE, Yan Q, Tsimikas JV, Feng Z. Estimation of smooth ROC curves for biomarkers with limits of detection. Statistics in Medicine. PMID 28786136 DOI: 10.1002/Sim.7394 |
0.353 |
|
| 2017 |
Shen W, Ning J, Yuan Y, Lok AS, Feng Z. Model-free scoring system for risk prediction with application to hepatocellular carcinoma study. Biometrics. PMID 28742219 DOI: 10.1111/Biom.12750 |
0.302 |
|
| 2017 |
Sanda MG, Feng Z, Howard DH, Tomlins SA, Sokoll LJ, Chan DW, Regan MM, Groskopf J, Chipman J, Patil DH, Salami SS, Scherr DS, Kagan J, Srivastava S, Thompson IM, et al. Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer. Jama Oncology. PMID 28520829 DOI: 10.1001/jamaoncol.2017.0177 |
0.302 |
|
| 2017 |
Capello M, Bantis LE, Scelo G, Zhao Y, Li P, Dhillon DS, Patel NJ, Kundnani DL, Wang H, Abbruzzese JL, Maitra A, Tempero MA, Brand R, Foretova L, Fabianova E, ... ... Feng Z, et al. Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. Journal of the National Cancer Institute. 109. PMID 28376157 DOI: 10.1093/Jnci/Djw266 |
0.309 |
|
| 2017 |
Rubicz R, Zhao S, Wright JL, Coleman I, Grasso C, Geybels MS, Leonardson A, Kolb S, April C, Bibikova M, Troyer D, Lance R, Lin DW, Ostrander EA, Nelson PS, ... ... Feng Z, et al. Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer. Molecular Oncology. 11: 140-150. PMID 28145099 DOI: 10.1002/1878-0261.12014 |
0.395 |
|
| 2017 |
Jhun MA, Geybels MS, Wright JL, Kolb S, April C, Bibikova M, Ostrander EA, Fan J, Feng Z, Stanford JL. Abstract 4957: Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort Epidemiology. 77: 4957-4957. DOI: 10.1158/1538-7445.Am2017-4957 |
0.395 |
|
| 2016 |
Eminaga O, Wei W, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, ... Feng Z, et al. MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study. Plos One. 11: e0165236. PMID 27846218 DOI: 10.1371/Journal.Pone.0165236 |
0.435 |
|
| 2016 |
Geybels MS, Wright JL, Bibikova M, Klotzle B, Fan JB, Zhao S, Feng Z, Ostrander EA, Lin DW, Nelson PS, Stanford JL. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy. Clinical Epigenetics. 8: 97. PMID 27651837 DOI: 10.1186/S13148-016-0260-Z |
0.42 |
|
| 2016 |
McKenney JK, Wei W, Hawley S, Auman H, Newcomb LF, Boyer HD, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Tretiakova MS, Vakar-Lopez F, Carroll PR, Cooperberg MR, Gleave ME, ... ... Feng Z, et al. Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort. The American Journal of Surgical Pathology. PMID 27635949 DOI: 10.1097/Pas.0000000000000736 |
0.38 |
|
| 2016 |
Lotan TL, Wei W, Morais CL, Hawley ST, Fazli L, Hurtado-Coll A, Troyer D, McKenney JK, Simko J, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, ... ... Feng Z, et al. PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer. European Urology Focus. 2: 180-188. PMID 27617307 DOI: 10.1016/J.Euf.2015.07.005 |
0.412 |
|
| 2016 |
Zhao S, Geybels MS, Leonardson A, Rubicz R, Kolb S, Yan Q, Klotzle B, Bibikova M, Hurtado-Coll A, Troyer D, Lance R, Lin D, Wright JL, Ostrander EA, Fan JB, ... Feng Z, et al. Epigenome-wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-lethal Progression in Men with Clinically Localized Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27358489 DOI: 10.1158/1078-0432.Ccr-16-0549 |
0.424 |
|
| 2016 |
Brooks JD, Wei W, Pollack JR, West RB, Shin JH, Sunwoo JB, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, ... ... Feng Z, et al. Loss of expression of AZGP1 is associated with worse clinical outcomes in a multi-institutional radical prostatectomy cohort. The Prostate. PMID 27325561 DOI: 10.1002/Pros.23225 |
0.337 |
|
| 2016 |
Bantis LE, Feng Z. Comparison of two correlated ROC curves at a given specificity or sensitivity level. Statistics in Medicine. PMID 27324068 DOI: 10.1002/Sim.7008 |
0.345 |
|
| 2016 |
Fu R, Wang P, Ma W, Taguchi A, Wong CH, Zhang Q, Gazdar A, Hanash SM, Zhou Q, Zhong H, Feng Z. A statistical method for detecting differentially expressed SNVs based on next-generation RNA-seq data. Biometrics. PMID 27276420 DOI: 10.1111/Biom.12548 |
0.306 |
|
| 2016 |
Lotan TL, Wei W, Ludkovski O, Morais CL, Guedes LB, Jamaspishvili T, Lopez K, Hawley ST, Feng Z, Fazli L, Hurtado-Coll A, McKenney JK, Simko J, Carroll PR, Gleave M, et al. Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27174589 DOI: 10.1038/Modpathol.2016.88 |
0.33 |
|
| 2016 |
Tretiakova MS, Wei W, Boyer HD, Newcomb LF, Hawley S, Auman H, Vakar-Lopez F, McKenney JK, Fazli L, Simko J, Troyer DA, Hurtado-Coll A, Thompson IM, Carroll PR, Ellis WJ, ... ... Feng Z, et al. Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies. Prostate Cancer and Prostatic Diseases. PMID 27136741 DOI: 10.1038/Pcan.2016.12 |
0.427 |
|
| 2016 |
Pepe MS, Janes H, Li CI, Bossuyt PM, Feng Z, Hilden J. Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility? Clinical Chemistry. PMID 27001493 DOI: 10.1373/Clinchem.2015.252163 |
0.34 |
|
| 2016 |
Rubicz R, Zhao S, Geybels M, Wright JL, Kolb S, Klotzle B, Bibikova M, Troyer D, Lance R, Ostrander EA, Feng Z, Fan JB, Stanford JL. DNA methylation profiles in African American prostate cancer patients in relation to disease progression. Genomics. PMID 26902887 DOI: 10.1016/J.Ygeno.2016.02.004 |
0.414 |
|
| 2016 |
Tayob N, Do KA, Feng Z. Unbiased estimation of biomarker panel performance when combining training and testing data in a group sequential design. Biometrics. PMID 26845527 DOI: 10.1111/Biom.12480 |
0.34 |
|
| 2016 |
Ruhaak LR, Stroble C, Dai J, Barnett MJ, Taguchi A, Goodman GE, Miyamoto S, Gandara DR, Feng Z, Lebrilla C, Hanash SM. Serum glycans as risk markers for non-small cell lung cancer. Cancer Prevention Research (Philadelphia, Pa.). PMID 26813970 DOI: 10.1158/1940-6207.Capr-15-0033 |
0.363 |
|
| 2016 |
Huang X, Yan F, Ning J, Feng Z, Choi S, Cortes J. A two-stage approach for dynamic prediction of time-to-event distributions. Statistics in Medicine. PMID 26748812 DOI: 10.1002/Sim.6860 |
0.312 |
|
| 2016 |
Capello M, Bantis LE, Scelo G, Zhao Y, Dhillon DS, Wang H, Abbruzzese JL, Maitra A, Tempero MA, Brand R, Firpo MA, Mulvihill S, Katz MH, Brennan P, Feng Z, et al. Abstract LB-134: Sequential validation of blood-based protein biomarker candidates for early-stage pancreatic cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-134 |
0.349 |
|
| 2015 |
Geybels MS, Alumkal JJ, Luedeke M, Rinckleb A, Zhao S, Shui IM, Bibikova M, Klotzle B, van den Brandt PA, Ostrander EA, Fan JB, Feng Z, Maier C, Stanford JL. Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors. Clinical Epigenetics. 7: 128. PMID 26692910 DOI: 10.1186/S13148-015-0161-6 |
0.365 |
|
| 2015 |
Koopmeiners JS, Feng Z. Group sequential testing of the predictive accuracy of a continuous biomarker with unknown prevalence. Statistics in Medicine. PMID 26537180 DOI: 10.1002/Sim.6790 |
0.598 |
|
| 2015 |
Pepe MS, Fan J, Feng Z, Gerds T, Hilden J. The Net Reclassification Index (NRI): a Misleading Measure of Prediction Improvement Even with Independent Test Data Sets. Statistics in Biosciences. 7: 282-295. PMID 26504496 DOI: 10.1007/S12561-014-9118-0 |
0.301 |
|
| 2015 |
Geybels MS, Zhao S, Wong CJ, Bibikova M, Klotzle B, Wu M, Ostrander EA, Fan JB, Feng Z, Stanford JL. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue. The Prostate. PMID 26383847 DOI: 10.1002/Pros.23093 |
0.36 |
|
| 2015 |
Taguchi A, Rho JH, Yan Q, Zhang Y, Zhao Y, Xu H, Tripathi SC, Wang H, Brenner D, Kucherlapati M, Kucherlapati RS, Boutin A, Wang YA, DePinho RA, Feng Z, et al. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas. Cancer Prevention Research (Philadelphia, Pa.). PMID 26342024 DOI: 10.1158/1940-6207.Capr-15-0077 |
0.382 |
|
| 2015 |
Newcomb LF, Thompson IM, Boyer HD, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Ellis WJ, Fazli L, Feng Z, Gleave ME, Kunju P, Lance RS, McKenney JK, Meng MV, et al. Outcomes of active surveillance for the management of clinically localized prostate cancer in the prospective, multi-institutional Canary PASS cohort. The Journal of Urology. PMID 26327354 DOI: 10.1016/J.Juro.2015.08.087 |
0.387 |
|
| 2015 |
Wikoff WR, Hanash S, DeFelice B, Miyamoto S, Barnett M, Zhao Y, Goodman G, Feng Z, Gandara D, Fiehn O, Taguchi A. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26282655 DOI: 10.1200/Jco.2015.61.7779 |
0.343 |
|
| 2015 |
Fowke JH, McLerran DF, Gupta PC, He J, Shu XO, Ramadas K, Tsugane S, Inoue M, Tamakoshi A, Koh WP, Nishino Y, Tsuji I, Ozasa K, Yuan JM, Tanaka H, ... ... Feng Z, et al. Associations of Body Mass Index, Smoking, and Alcohol Consumption With Prostate Cancer Mortality in the Asia Cohort Consortium. American Journal of Epidemiology. PMID 26243736 DOI: 10.1093/Aje/Kwv089 |
0.401 |
|
| 2015 |
Brooks JD, Wei W, Hawley S, Auman H, Newcomb L, Boyer H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, ... ... Feng Z, et al. Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients. Plos One. 10: e0132343. PMID 26172920 DOI: 10.1371/Journal.Pone.0132343 |
0.443 |
|
| 2015 |
Rubicz R, Zhao S, April C, Wright JL, Kolb S, Coleman I, Lin DW, Nelson PS, Ostrander EA, Feng Z, Fan JB, Stanford JL. Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort. The Prostate. PMID 25990700 DOI: 10.1002/Pros.23016 |
0.375 |
|
| 2015 |
Ma GX, Fang C, Tan Y, Feng Z, Ge S, Nguyen C. Increasing cervical cancer screening among vietnamese americans: a community-based intervention trial. Journal of Health Care For the Poor and Underserved. 26: 36-52. PMID 25981087 DOI: 10.1353/Hpu.2015.0064 |
0.302 |
|
| 2015 |
Zhao S, Zheng Y, Prentice RL, Feng Z. Two-stage biomarker panel study and estimation allowing early termination for futility. Biostatistics (Oxford, England). 16: 799-812. PMID 25964662 DOI: 10.1093/Biostatistics/Kxv017 |
0.378 |
|
| 2015 |
Penney KL, Shui IM, Feng Z, Sesso HD, Stampfer MJ, Stanford JL. Replication of a genetic variant for prostate cancer-specific mortality. Prostate Cancer and Prostatic Diseases. PMID 25939514 DOI: 10.1038/Pcan.2015.18 |
0.386 |
|
| 2015 |
Troyer DA, Jamaspishvili T, Wei W, Feng Z, Good J, Hawley S, Fazli L, McKenney JK, Simko J, Hurtado-Coll A, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, et al. A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer. The Prostate. 75: 1206-15. PMID 25939393 DOI: 10.1002/Pros.23003 |
0.428 |
|
| 2015 |
Birnbaum JK, Feng Z, Gulati R, Fan J, Lotan Y, Wei JT, Etzioni R. Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 677-82. PMID 25613117 DOI: 10.1158/1055-9965.Epi-14-1224 |
0.435 |
|
| 2015 |
Karyadi DM, Zhao S, He Q, McIntosh L, Wright JL, Ostrander EA, Feng Z, Stanford JL. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families. International Journal of Cancer. Journal International Du Cancer. 136: 2166-71. PMID 25273821 DOI: 10.1002/Ijc.29241 |
0.395 |
|
| 2015 |
Taguchi A, Capello M, Zhao Y, Babel I, Goodman G, Tempero MA, Firpo MA, Katz MH, Feng Z, Hanash S. Abstract B20: Development and validation of diagnostic biomarker model for detection of early stage pancreatic cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-B20 |
0.35 |
|
| 2015 |
Sanda M, Feng Z, Wei J, Howard D, Rubin M, Groskopf J, Sokoll L, Chan D, Regan M, Patil D, Salami S, Siddiqui J, Scherr D, Kagan J, Srivastava S, et al. Pi-08 Combining Urine Pca3 And Tmprss2: Erg Tests To Refine Prostate Cancer Detection – Validation Study And Health Economic Analysis The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2907 |
0.4 |
|
| 2015 |
Lotan TL, Morais CL, Wei W, Jamaspishvili T, Feng Z, McKenney J, Simko J, Troyer D, True L, Brooks JD, Squire J, Biomarkers CPTIT. Mp1-17 Pten Status Determination In Prostate Cancer: Comparison Of Ihc And Fish In A Large Multi-Center Cohort The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.180 |
0.417 |
|
| 2014 |
Wei JT, Feng Z, Partin AW, Brown E, Thompson I, Sokoll L, Chan DW, Lotan Y, Kibel AS, Busby JE, Bidair M, Lin DW, Taneja SS, Viterbo R, Joon AY, et al. Can urinary PCA3 supplement PSA in the early detection of prostate cancer? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 4066-72. PMID 25385735 DOI: 10.1200/Jco.2013.52.8505 |
0.433 |
|
| 2014 |
Stott-Miller M, Zhao S, Wright JL, Kolb S, Bibikova M, Klotzle B, Ostrander EA, Fan JB, Feng Z, Stanford JL. Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1331-9. PMID 24718283 DOI: 10.1158/1055-9965.Epi-13-1000 |
0.425 |
|
| 2014 |
Hubers AJ, van der Drift MA, Prinsen CF, Witte BI, Wang Y, Shivapurkar N, Stastny V, Bolijn AS, Hol BE, Feng Z, Dekhuijzen PN, Gazdar AF, Thunnissen E. Methylation analysis in spontaneous sputum for lung cancer diagnosis. Lung Cancer (Amsterdam, Netherlands). 84: 127-33. PMID 24598366 DOI: 10.1016/J.Lungcan.2014.01.019 |
0.358 |
|
| 2014 |
Sin DD, Tammemagi CM, Lam S, Barnett MJ, Duan X, Tam A, Auman H, Feng Z, Goodman GE, Hanash SM, Taguchi A. Abstract PR08: Pro-surfactant protein B as a biomarker for lung cancer prediction. Clinical Cancer Research. 20. DOI: 10.1158/1078-0432.14Aacriaslc-Pr08 |
0.363 |
|
| 2014 |
Troyer D, Jamaspishvili T, Good J, Squire J, Wei W, Feng Z. Mp79-14 Fish Analysis Of 637 Prostate Cancers: Association Of Pten Genomic Deletion With Earlier Onset Of Disease Progression And Worse Prognosis The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.2517 |
0.395 |
|
| 2013 |
Brown EC, Cooperberg MR, Newcomb LF, Carroll P, Feng Z, Gleave ME, Lance R, Sanda MG, Thompson IM, Wei JT, Nelson P, Lin DW. Association of declining PSA values with a lower risk of progression in the Canary Prostate Cancer Active Surveillance Study (PASS). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 88. PMID 28137123 DOI: 10.1200/Jco.2013.31.6_Suppl.88 |
0.403 |
|
| 2013 |
Sin DD, Tammemagi CM, Lam S, Barnett MJ, Duan X, Tam A, Auman H, Feng Z, Goodman GE, Hanash S, Taguchi A. Pro-surfactant protein B as a biomarker for lung cancer prediction. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4536-43. PMID 24248694 DOI: 10.1200/Jco.2013.50.6105 |
0.333 |
|
| 2013 |
Holt SK, Kolb S, Fu R, Horst R, Feng Z, Stanford JL. Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis. Cancer Epidemiology. 37: 666-70. PMID 23972671 DOI: 10.1016/J.Canep.2013.07.005 |
0.38 |
|
| 2013 |
Geybels MS, Wright JL, Holt SK, Kolb S, Feng Z, Stanford JL. Statin use in relation to prostate cancer outcomes in a population-based patient cohort study. The Prostate. 73: 1214-22. PMID 23633265 DOI: 10.1002/Pros.22671 |
0.422 |
|
| 2013 |
Lin DW, Newcomb LF, Brown EC, Brooks JD, Carroll PR, Feng Z, Gleave ME, Lance RS, Sanda MG, Thompson IM, Wei JT, Nelson PS. Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2442-50. PMID 23515404 DOI: 10.1158/1078-0432.Ccr-12-3283 |
0.424 |
|
| 2013 |
Ma GX, Gao W, Fang CY, Tan Y, Feng Z, Ge S, Nguyen JA. Health beliefs associated with cervical cancer screening among Vietnamese Americans. Journal of Women's Health (2002). 22: 276-88. PMID 23428284 DOI: 10.1089/Jwh.2012.3587 |
0.312 |
|
| 2013 |
Ankerst DP, Till C, Boeck A, Goodman P, Tangen CM, Feng Z, Partin AW, Chan DW, Sokoll L, Kagan J, Wei JT, Thompson IM. The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator. The Journal of Urology. 190: 70-6. PMID 23313212 DOI: 10.1016/J.Juro.2012.12.108 |
0.432 |
|
| 2013 |
Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M, Hernandez J, Hurtado-Coll A, Kuchinsky K, Liew J, Mendez-Meza R, ... ... Feng Z, et al. A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray. Advances in Anatomic Pathology. 20: 39-44. PMID 23232570 DOI: 10.1097/Pap.0B013E31827B665B |
0.419 |
|
| 2013 |
Feng Z, Kagan J, Pepe M, Thornquist M, Ann Rinaudo J, Dahlgren J, Krueger K, Zheng Y, Patriotis C, Huang Y, Sorbara L, Thompson I, Srivastava S. The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers. Clinical Chemistry. 59: 68-74. PMID 23193062 DOI: 10.1373/Clinchem.2012.185140 |
0.327 |
|
| 2013 |
Takahashi T, Shigematsu H, Shivapurkar N, Reddy J, Zheng Y, Feng Z, Suzuki M, Nomura M, Augustus M, Yin J, Meltzer SJ, Gazdar AF. Erratum: Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers(International Journal of Cancer (2012) 132 (499)) International Journal of Cancer. 132. PMID 23169200 DOI: 10.1002/Ijc.27883 |
0.351 |
|
| 2013 |
Geybels MS, Hutter CM, Kwon EM, Ostrander EA, Fu R, Feng Z, Stanford JL, Peters U. Variation in selenoenzyme genes and prostate cancer risk and survival. The Prostate. 73: 734-42. PMID 23143801 DOI: 10.1002/Pros.22617 |
0.417 |
|
| 2013 |
Lin Y, Fu R, Grant E, Chen Y, Lee JE, Gupta PC, Ramadas K, Inoue M, Tsugane S, Gao YT, Tamakoshi A, Shu XO, Ozasa K, Tsuji I, Kakizaki M, ... ... Feng Z, et al. Association of body mass index and risk of death from pancreatic cancer in Asians: findings from the Asia Cohort Consortium. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 22: 244-50. PMID 23044748 DOI: 10.1097/Cej.0B013E3283592Cef |
0.346 |
|
| 2013 |
Liang Y, Ankerst DP, Feng Z, Fu R, Stanford JL, Thompson IM. The risk of biopsy-detectable prostate cancer using the prostate cancer prevention trial risk calculator in a community setting Urologic Oncology: Seminars and Original Investigations. 31: 1464-1469. PMID 22552047 DOI: 10.1016/J.Urolonc.2012.03.012 |
0.429 |
|
| 2013 |
Holt SK, Kwon EM, Fu R, Kolb S, Feng Z, Ostrander EA, Stanford JL. Association of variants in estrogen-related pathway genes with prostate cancer risk Prostate. 73: 1-10. PMID 22549291 DOI: 10.1002/Pros.22534 |
0.41 |
|
| 2013 |
Huang Y, Pepe MS, Feng Z. Logistic regression analysis with standardized markers The Annals of Applied Statistics. 7: 1640-1662. DOI: 10.1214/13-Aoas634 |
0.407 |
|
| 2013 |
Cooperberg MR, Newcomb LF, Brown EC, Zhao S, Feng Z, Brooks JD, Lin DW, Investigators CP. The impact of reducing the frequency of prostate specific antigen (PSA) testing among men on active surveillance for prostate cancer. Journal of Clinical Oncology. 31: 5092-5092. DOI: 10.1200/Jco.2013.31.15_Suppl.5092 |
0.402 |
|
| 2012 |
Lin DW, Newcomb LF, Brown EC, Brooks JD, Carroll P, Feng Z, Gleave ME, Lance R, Sanda MG, Thompson IM, Wei J, Nelson P. Urinary TMPRSS2: Use of ERG and PCA3 to predict tumor volume and Gleason grade in an active surveillance cohort-Results from the Canary/EDRN Prostate Active Surveillance Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2. PMID 27968277 DOI: 10.1200/Jco.2012.30.5_Suppl.2 |
0.422 |
|
| 2012 |
Lu H, Ladd J, Feng Z, Wu M, Goodell V, Pitteri SJ, Li CI, Prentice R, Hanash SM, Disis ML. Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera. Cancer Prevention Research (Philadelphia, Pa.). 5: 1036-43. PMID 22715141 DOI: 10.1158/1940-6207.Capr-11-0558 |
0.316 |
|
| 2012 |
Hazelton WD, Goodman G, Rom WN, Tockman M, Thornquist M, Moolgavkar S, Weissfeld JL, Feng Z. Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers. Mathematical Biosciences. 240: 20-34. PMID 22705252 DOI: 10.1016/J.Mbs.2012.05.008 |
0.334 |
|
| 2012 |
Elashoff D, Zhou H, Reiss J, Wang J, Xiao H, Henson B, Hu S, Arellano M, Sinha U, Le A, Messadi D, Wang M, Nabili V, Lingen M, Morris D, ... ... Feng Z, et al. Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 664-72. PMID 22301830 DOI: 10.1158/1055-9965.Epi-11-1093 |
0.377 |
|
| 2012 |
Ladd JJ, Busald T, Johnson MM, Zhang Q, Pitteri SJ, Wang H, Brenner DE, Lampe PD, Kucherlapati R, Feng Z, Prentice RL, Hanash SM. Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. Cancer Prevention Research (Philadelphia, Pa.). 5: 655-64. PMID 22277732 DOI: 10.1158/1940-6207.Capr-11-0412 |
0.345 |
|
| 2012 |
Koopmeiners JS, Feng Z, Pepe MS. Conditional estimation after a two-stage diagnostic biomarker study that allows early termination for futility. Statistics in Medicine. 31: 420-35. PMID 22238117 DOI: 10.1002/Sim.4430 |
0.569 |
|
| 2012 |
Zheng Y, Cai T, Jin Y, Feng Z. Evaluating prognostic accuracy of biomarkers under competing risk. Biometrics. 68: 388-96. PMID 22150576 DOI: 10.1111/J.1541-0420.2011.01671.X |
0.358 |
|
| 2012 |
Ankerst DP, Koniarski T, Liang Y, Leach RJ, Feng Z, Sanda MG, Partin AW, Chan DW, Kagan J, Sokoll L, Wei JT, Thompson IM. Updating risk prediction tools: a case study in prostate cancer. Biometrical Journal. Biometrische Zeitschrift. 54: 127-42. PMID 22095849 DOI: 10.1002/Bimj.201100062 |
0.393 |
|
| 2012 |
Feng Z. Abstract ED03-02: Biomarker statistical design Cancer Prevention Research. 5. DOI: 10.1158/1940-6207.Prev-12-Ed03-02 |
0.387 |
|
| 2012 |
Wei JT, Sanda MG, Thompson IM, Partin A, Feng Z, Sokoll L, Groskopf J, Brown E, Lotan Y, Kibel A, Lin D, Taneja S, Viterbo R, Busby E, Bidair M, et al. Abstract 4451: The NCI Early Detection Research Network (EDRN) urinary PCA3 validation trial Cancer Research. 72: 4451-4451. DOI: 10.1158/1538-7445.Am2012-4451 |
0.458 |
|
| 2012 |
Lin D, Newcomb L, Ellis W, Gleave M, Thompson I, Brooks J, Nelson P, Sanda M, Lance R, Wei J, Feng Z, Carroll P. 990 Progression And Treatment In A Multi-Institutional, Prospective Active Surveillance Study: Results From Canary Prostate Active Surveillance Study (Pass) The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1091 |
0.332 |
|
| 2011 |
Koopmeiners JS, Feng Z. Asymptotic Properties of the Sequential Empirical ROC, PPV and NPV Curves Under Case-Control Sampling. Annals of Statistics. 39: 3234-3261. PMID 24039313 DOI: 10.1214/11-Aos937 |
0.573 |
|
| 2011 |
Huang Y, Fong Y, Wei J, Feng Z. Borrowing Information across Populations in Estimating Positive and Negative Predictive Values. Journal of the Royal Statistical Society. Series C, Applied Statistics. 60: 633-653. PMID 22021938 DOI: 10.1111/J.1467-9876.2011.00761.X |
0.312 |
|
| 2011 |
Lin DW, FitzGerald LM, Fu R, Kwon EM, Zheng SL, Kolb S, Wiklund F, Stattin P, Isaacs WB, Xu J, Ostrander EA, Feng Z, Grönberg H, Stanford JL. Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1928-36. PMID 21846818 DOI: 10.1158/1055-9965.Epi-11-0236 |
0.435 |
|
| 2011 |
FitzGerald LM, Kwon EM, Conomos MP, Kolb S, Holt SK, Levine D, Feng Z, Ostrander EA, Stanford JL. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1196-203. PMID 21467234 DOI: 10.1158/1055-9965.Epi-10-1299 |
0.43 |
|
| 2011 |
Kwon EM, Salinas CA, Kolb S, Fu R, Feng Z, Stanford JL, Ostrander EA. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 923-33. PMID 21430300 DOI: 10.1158/1055-9965.Epi-10-0994 |
0.393 |
|
| 2011 |
Risques RA, Lai LA, Himmetoglu C, Ebaee A, Li L, Feng Z, Bronner MP, Al-Lahham B, Kowdley KV, Lindor KD, Rabinovitch PS, Brentnall TA. Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Research. 71: 1669-79. PMID 21363920 DOI: 10.1158/0008-5472.Can-10-1966 |
0.325 |
|
| 2011 |
Checkoway H, Ray RM, Lundin JI, Astrakianakis G, Seixas NS, Camp JE, Wernli KJ, Fitzgibbons ED, Li W, Feng Z, Gao DL, Thomas DB. Lung cancer and occupational exposures other than cotton dust and endotoxin among women textile workers in Shanghai, China. Occupational and Environmental Medicine. 68: 425-9. PMID 21131604 DOI: 10.1136/Oem.2010.059519 |
0.303 |
|
| 2011 |
Wright JL, Neuhouser ML, Lin DW, Kwon EM, Feng Z, Ostrander EA, Stanford JL. AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk. The Prostate. 71: 498-506. PMID 20945498 DOI: 10.1002/Pros.21267 |
0.393 |
|
| 2011 |
Huang Y, Isharwal S, Haese A, Chun FKH, Makarov DV, Feng Z, Han M, Humphreys E, Epstein JI, Partin AW, Veltri RW. Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous PSA measurement, Clinical Stage and biopsy Gleason score Bjui. 107: 1562. PMID 20875091 DOI: 10.1111/J.1464-410X.2010.09692.X |
0.313 |
|
| 2011 |
Yue T, Maupin K, Partyka K, Li L, Anderson MA, Brenner D, Simeone D, Feng Z, Brand RE, Haab BB. Abstract 2216: Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers Cancer Research. 71: 2216-2216. DOI: 10.1158/1538-7445.Am2011-2216 |
0.304 |
|
| 2010 |
Salinas CA, Kwon EM, FitzGerald LM, Feng Z, Nelson PS, Ostrander EA, Peters U, Stanford JL. Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. American Journal of Epidemiology. 172: 578-90. PMID 20688905 DOI: 10.1093/Aje/Kwq175 |
0.428 |
|
| 2010 |
Holt SK, Kwon EM, Koopmeiners JS, Lin DW, Feng Z, Ostrander EA, Peters U, Stanford JL. Vitamin D pathway gene variants and prostate cancer prognosis. The Prostate. 70: 1448-60. PMID 20687218 DOI: 10.1002/Pros.21180 |
0.599 |
|
| 2010 |
Wright JL, Kwon EM, Lin DW, Kolb S, Koopmeiners JS, Feng Z, Ostrander EA, Stanford JL. CYP17 polymorphisms and prostate cancer outcomes. The Prostate. 70: 1094-101. PMID 20503394 DOI: 10.1002/Pros.21143 |
0.638 |
|
| 2010 |
Sokoll LJ, Sanda MG, Feng Z, Kagan J, Mizrahi IA, Broyles DL, Partin AW, Srivastava S, Thompson IM, Wei JT, Zhang Z, Chan DW. A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1193-200. PMID 20447916 DOI: 10.1158/1055-9965.Epi-10-0007 |
0.441 |
|
| 2010 |
Haab BB, Porter A, Yue T, Li L, Scheiman J, Anderson MA, Barnes D, Schmidt CM, Feng Z, Simeone DM. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Annals of Surgery. 251: 937-45. PMID 20395854 DOI: 10.1097/Sla.0B013E3181D7738D |
0.3 |
|
| 2010 |
Langeberg WJ, Tahir SA, Feng Z, Kwon EM, Ostrander EA, Thompson TC, Stanford JL. Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes. The Prostate. 70: 1020-35. PMID 20209490 DOI: 10.1002/Pros.21137 |
0.395 |
|
| 2010 |
Wang CY, Feng Z. Boosting with missing predictors. Biostatistics (Oxford, England). 11: 195-212. PMID 19948743 DOI: 10.1093/Biostatistics/Kxp052 |
0.329 |
|
| 2010 |
Newcomb LF, Brooks JD, Carroll PR, Feng Z, Gleave ME, Nelson PS, Thompson IM, Lin DW. Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository. Urology. 75: 407-13. PMID 19758683 DOI: 10.1016/J.Urology.2009.05.050 |
0.423 |
|
| 2010 |
Zheng Y, Cai T, Stanford JL, Feng Z. Semiparametric models of time-dependent predictive values of prognostic biomarkers. Biometrics. 66: 50-60. PMID 19397579 DOI: 10.1111/J.1541-0420.2009.01246.X |
0.361 |
|
| 2010 |
Zhang L, Xiao H, Karlan S, Zhou H, Feng Z, Elashoff D, Akin D, Yan X, Chia D, Gross J, Karlan B, Wong DT. Abstract 2726: Salivary biomarkers for breast cancer detection Cancer Research. 70: 2726-2726. DOI: 10.1158/1538-7445.Am10-2726 |
0.365 |
|
| 2010 |
Wright JL, Neuhouser ML, Lin DW, Kwon EM, Feng Z, Ostrander EA, Stanford JL. 2055 AMACR POLYMORPHISMS, DIETARY INTAKE AND PROSTATE CANCER RISK Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.2102 |
0.408 |
|
| 2009 |
Wright JL, Salinas CA, Lin DW, Kolb S, Koopmeiners J, Feng Z, Stanford JL. Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. The Journal of Urology. 182: 2702-7. PMID 19836772 DOI: 10.1016/J.Juro.2009.08.026 |
0.652 |
|
| 2009 |
Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, Olaru AV, Paun BC, Yang J, Kan T, Ito T, Hamilton JP, Selaru FM, Agarwal R, David S, ... ... Feng Z, et al. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Research. 69: 4112-5. PMID 19435894 DOI: 10.1158/0008-5472.Can-09-0028 |
0.327 |
|
| 2009 |
Pepe MS, Feng Z, Longton G, Koopmeiners J. Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility. Statistics in Medicine. 28: 762-79. PMID 19097251 DOI: 10.1002/Sim.3506 |
0.564 |
|
| 2009 |
Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. The Prostate. 69: 363-72. PMID 19058137 DOI: 10.1002/Pros.20887 |
0.652 |
|
| 2009 |
Wright JL, Lin DW, Kwon EM, Kolb S, Feng Z, Koopmeiners J, Ostrander EA, Stanford JL. CYP17 POLYMORPHISMS AND PROSTATE CANCER OUTCOMES Journal of Urology. 181: 777-777. DOI: 10.1016/S0022-5347(09)62164-9 |
0.638 |
|
| 2009 |
Sokoll LJ, Liu Y, Feng Z, Kagan J, Partin AW, Srivastava S, Thompson IM, Wei JT, Elliott D, Sanda MG, Chan DW. [-2]Propsa For Prostate Cancer Detection: A Prospective, Multicenter, Nci Early Detection Research Network Study The Journal of Urology. 181: 772-772. DOI: 10.1016/S0022-5347(09)62151-0 |
0.383 |
|
| 2008 |
Wong DT, Wang J, Reiss J, Zimmermann B, Zhou H, Elashoff D, Morris D, Randolph T, Feng Z, Chia D. NCI-EDRN validation of salivary oral cancer biomarkers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 6010. PMID 27950682 DOI: 10.1200/Jco.2008.26.15_Suppl.6010 |
0.36 |
|
| 2008 |
Lin H, Feng Z, Yu Y, Zheng Y, Shivapurkar N, Gazdar AF. Application of Multidimensional Selective Item Response Regression Model for Studying Multiple Gene Methylation in SV40 Oncogenic Pathways. Journal of the American Statistical Association. 103: 201-211. PMID 19830254 DOI: 10.1198/016214507000000428 |
0.307 |
|
| 2008 |
Clark JP, Munson KW, Gu JW, Lamparska-Kupsik K, Chan KG, Yoshida JS, Kawachi MH, Crocitto LE, Wilson TG, Feng Z, Smith SS. Performance of a single assay for both type III and type VI TMPRSS2:ERG fusions in noninvasive prediction of prostate biopsy outcome. Clinical Chemistry. 54: 2007-17. PMID 18948370 DOI: 10.1373/Clinchem.2008.108845 |
0.394 |
|
| 2008 |
Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. Journal of the National Cancer Institute. 100: 1432-8. PMID 18840817 DOI: 10.1093/Jnci/Djn326 |
0.313 |
|
| 2008 |
Wernli KJ, Ray RM, Gao DL, Fitzgibbons ED, Camp JE, Astrakianakis G, Seixas N, Li W, De Roos AJ, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for endometrial cancer among textile workers in Shanghai, China. American Journal of Industrial Medicine. 51: 673-9. PMID 18626909 DOI: 10.1002/Ajim.20614 |
0.35 |
|
| 2008 |
Sokoll LJ, Wang Y, Feng Z, Kagan J, Partin AW, Sanda MG, Thompson IM, Chan DW. [-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study. The Journal of Urology. 180: 539-43; discussion 5. PMID 18550118 DOI: 10.1016/J.Juro.2008.04.015 |
0.413 |
|
| 2008 |
Salinas CA, Kwon E, Carlson CS, Koopmeiners JS, Feng Z, Karyadi DM, Ostrander EA, Stanford JL. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1203-13. PMID 18483343 DOI: 10.1158/1055-9965.Epi-07-2811 |
0.613 |
|
| 2008 |
Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL. 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. The Journal of Urology. 179: S40-4. PMID 18405749 DOI: 10.1016/J.Juro.2008.03.136 |
0.311 |
|
| 2008 |
Sato F, Jin Z, Schulmann K, Wang J, Greenwald BD, Ito T, Kan T, Hamilton JP, Yang J, Paun B, David S, Olaru A, Cheng Y, Mori Y, Abraham JM, ... ... Feng Z, et al. Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features. Plos One. 3: e1890. PMID 18382671 DOI: 10.1371/Journal.Pone.0001890 |
0.306 |
|
| 2008 |
Wernli KJ, Ray RM, Gao DL, Fitzgibbons ED, Camp JE, Astrakianakis G, Seixas N, Wong EY, Li W, De Roos AJ, Feng Z, Thomas DB, Checkoway H. Occupational exposures and ovarian cancer in textile workers. Epidemiology (Cambridge, Mass.). 19: 244-50. PMID 18300714 DOI: 10.1097/Ede.0B013E31816339F9 |
0.345 |
|
| 2008 |
Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y, Tenthorey J, Leiser A, Flores-Saaib R, Yu H, Azori M, Rutherford T, Schwartz PE, Mor G. Diagnostic markers for early detection of ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 1065-72. PMID 18258665 DOI: 10.1158/1078-0432.Ccr-07-1569 |
0.389 |
|
| 2008 |
McLerran D, Grizzle WE, Feng Z, Thompson IM, Bigbee WL, Cazares LH, Chan DW, Dahlgren J, Diaz J, Kagan J, Lin DW, Malik G, Oelschlager D, Partin A, Randolph TW, et al. SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clinical Chemistry. 54: 53-60. PMID 18024530 DOI: 10.1373/Clinchem.2007.091496 |
0.346 |
|
| 2008 |
Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, Zheng Y. Integrating the predictiveness of a marker with its performance as a classifier. American Journal of Epidemiology. 167: 362-8. PMID 17982157 DOI: 10.1093/Aje/Kwm305 |
0.366 |
|
| 2008 |
McLerran D, Grizzle WE, Feng Z, Bigbee WL, Banez LL, Cazares LH, Chan DW, Diaz J, Izbicka E, Kagan J, Malehorn DE, Malik G, Oelschlager D, Partin A, Randolph T, et al. Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. Clinical Chemistry. 54: 44-52. PMID 17981926 DOI: 10.1373/Clinchem.2007.091470 |
0.405 |
|
| 2008 |
Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y, Tenthorey J, Leiser A, Flores-Saaib R, Yu H, Azori M, Rutherford T, Schwartz PE, Mor G. Diagnostic markers for early detection of ovarian cancer (Clinical Cancer Research (2008) 14, (1065-1072)) Clinical Cancer Research. 14: 7158. DOI: 10.1158/1078-0432.Ccr-14-21-Cor |
0.374 |
|
| 2008 |
Clark JP, Munson KW, Lamparska-Kupsik K, Gu JW, Feng Z, Chan KG, Yoshida JS, Kawachi MH, Crocitto LE, Wilson TG, Smith SS. Serum Psa, Dre, Dna Methylation, Pca3, And Tmprss2:Erg In Expressed Prostatic Secretion As Non-Invasive Predictors Of Biopsy Outcome The Journal of Urology. 179: 706-706. DOI: 10.1016/S0022-5347(08)62056-X |
0.345 |
|
| 2007 |
Zheng Y, Katsaros D, Shan SJ, de la Longrais IR, Porpiglia M, Scorilas A, Kim NW, Wolfert RL, Simon I, Li L, Feng Z, Diamandis EP. A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 6984-92. PMID 18056174 DOI: 10.1158/1078-0432.Ccr-07-1409 |
0.333 |
|
| 2007 |
Huang Y, Pepe MS, Feng Z. Evaluating the Predictiveness of a Continuous Marker Biometrics. 63: 1181-1188. PMID 17489968 DOI: 10.1111/J.1541-0420.2007.00814.X |
0.375 |
|
| 2007 |
Ray RM, Gao DL, Li W, Wernli KJ, Astrakianakis G, Seixas NS, Camp JE, Fitzgibbons ED, Feng Z, Thomas DB, Checkoway H. Occupational exposures and breast cancer among women textile workers in Shanghai. Epidemiology (Cambridge, Mass.). 18: 383-92. PMID 17435449 DOI: 10.1097/01.Ede.0000259984.40934.Ae |
0.3 |
|
| 2007 |
Astrakianakis G, Seixas NS, Ray R, Camp JE, Gao DL, Feng Z, Li W, Wernli KJ, Fitzgibbons ED, Thomas DB, Checkoway H. Lung cancer risk among female textile workers exposed to endotoxin. Journal of the National Cancer Institute. 99: 357-64. PMID 17341727 DOI: 10.1093/Jnci/Djk063 |
0.305 |
|
| 2007 |
Shivapurkar N, Stastny V, Suzuki M, Wistuba II, Li L, Zheng Y, Feng Z, Hol B, Prinsen C, Thunnissen FB, Gazdar AF. Application of a methylation gene panel by quantitative PCR for lung cancers. Cancer Letters. 247: 56-71. PMID 16644104 DOI: 10.1016/J.Canlet.2006.03.020 |
0.366 |
|
| 2007 |
Thunnissen E, Shivapurkar N, Stastny V, Drift Mv, Bolijn A, Hol B, Yinghui W, Feng Z, Gazdar A, Prinsen C. B4-07: Sputum Methylation Analysis Detects Patients With Lung Cancer Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283166.73610.9D |
0.303 |
|
| 2006 |
Agalliu I, Lin DW, Salinas CA, Feng Z, Stanford JL. Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. The Prostate. 66: 1535-41. PMID 16921513 DOI: 10.1002/Pros.20491 |
0.39 |
|
| 2006 |
Li W, Ray RM, Gao DL, Fitzgibbons ED, Seixas NS, Camp JE, Wernli KJ, Astrakianakis G, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for pancreatic cancer among female textile workers in Shanghai, China. Occupational and Environmental Medicine. 63: 788-93. PMID 16847032 DOI: 10.1136/Oem.2005.026229 |
0.326 |
|
| 2006 |
Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, Feng Z, Parnes HL, Coltman CA. Assessing prostate cancer risk: Results from the Prostate Cancer Prevention Trial Journal of the National Cancer Institute. 98: 529-534. PMID 16622122 DOI: 10.1093/Jnci/Djj131 |
0.425 |
|
| 2006 |
Zheng Y, Cai T, Feng Z. Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers. Biometrics. 62: 279-87. PMID 16542256 DOI: 10.1111/J.1541-0420.2005.00441.X |
0.304 |
|
| 2006 |
Wernli KJ, Fitzgibbons ED, Ray RM, Gao DL, Li W, Seixas NS, Camp JE, Astrakianakis G, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for esophageal and stomach cancers among female textile workers in Shanghai, China. American Journal of Epidemiology. 163: 717-25. PMID 16467414 DOI: 10.1093/Aje/Kwj091 |
0.36 |
|
| 2006 |
Li W, Ray RM, Gao DL, Fitzgibbons ED, Seixas NS, Camp JE, Wernli KJ, Astrakianakis G, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for nasopharyngeal cancer among female textile workers in Shanghai, China. Occupational and Environmental Medicine. 63: 39-44. PMID 16361404 DOI: 10.1136/Oem.2005.021709 |
0.33 |
|
| 2006 |
Wong EY, Ray R, Gao DL, Wernli KJ, Li W, Fitzgibbons ED, Feng Z, Thomas DB, Checkoway H. Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China. International Archives of Occupational and Environmental Health. 79: 251-8. PMID 16220287 DOI: 10.1007/S00420-005-0036-9 |
0.344 |
|
| 2005 |
Orchekowski R, Hamelinck D, Li L, Gliwa E, vanBrocklin M, Marrero JA, Vande Woude GF, Feng Z, Brand R, Haab BB. Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. Cancer Research. 65: 11193-202. PMID 16322270 DOI: 10.1158/0008-5472.Can-05-1436 |
0.339 |
|
| 2005 |
Schulmann K, Sterian A, Berki A, Yin J, Sato F, Xu Y, Olaru A, Wang S, Mori Y, Deacu E, Hamilton J, Kan T, Krasna MJ, Beer DG, Pepe MS, ... ... Feng Z, et al. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene. 24: 4138-48. PMID 15824739 DOI: 10.1038/Sj.Onc.1208598 |
0.303 |
|
| 2005 |
Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. The Journal of Urology. 173: 1701-5. PMID 15821561 DOI: 10.1097/01.Ju.0000154637.38262.3A |
0.311 |
|
| 2005 |
Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, Kagan J, Malik G, McLerran D, Moul JW, Partin A, et al. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clinical Chemistry. 51: 102-12. PMID 15613711 DOI: 10.1373/Clinchem.2004.038950 |
0.425 |
|
| 2005 |
Orchekowski R, Hamelinck D, Li L, VanBrocklin M, Marrero J, VandeWoude G, Feng Z, Brand RE, Haab BB. SERUM-PROTEIN ALTERATIONS IN PANCREATIC CANCER PATIENTS AND THEIR USE FOR DISEASE CLASSIFICATION Pancreas. 31: 460. DOI: 10.1097/01.Mpa.0000193734.04168.Bd |
0.327 |
|
| 2004 |
Feng Z, Prentice R, Srivastava S. Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective Pharmacogenomics. 5: 709-719. PMID 15335291 DOI: 10.1517/14622416.5.6.709 |
0.303 |
|
| 2004 |
Feng Z, Yasui Y. Statistical considerations in combining biomarkers for disease classification. Disease Markers. 20: 45-51. PMID 15322313 DOI: 10.1155/2004/214152 |
0.32 |
|
| 2004 |
Grizzle WE, Semmes OJ, Basler J, Izbicka E, Feng Z, Kagan J, Adam BL, Troyer D, Srivastava S, Thornquist M, Zhang Z, Thompson IM. The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology. Urologic Oncology. 22: 337-43. PMID 15283893 DOI: 10.1016/J.Urolonc.2004.04.008 |
0.453 |
|
| 2004 |
Cheteri MB, Stanford JL, Friedrichsen DM, Peters MA, Iwasaki L, Langlois MC, Feng Z, Ostrander EA. Vitamin D receptor gene polymorphisms and prostate cancer risk. The Prostate. 59: 409-18. PMID 15065089 DOI: 10.1002/Pros.20001 |
0.434 |
|
| 2003 |
Grizzle WE, Adam BL, Bigbee WL, Conrads TP, Carroll C, Feng Z, Izbicka E, Jendoubi M, Johnsey D, Kagan J, Leach RJ, McCarthy DB, Semmes OJ, Srivastava S, Srivastava S, et al. Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer. Disease Markers. 19: 185-95. PMID 15258333 DOI: 10.1155/2004/546293 |
0.353 |
|
| 2003 |
Yasui Y, McLerran D, Adam BL, Winget M, Thornquist M, Feng Z. An Automated Peak Identification/Calibration Procedure for High-Dimensional Protein Measures From Mass Spectrometers Biomed Research International. 2003: 242-248. PMID 14615632 DOI: 10.1155/S111072430320927X |
0.301 |
|
| 2003 |
Yasui Y, Pepe M, Thompson ML, Adam BL, Wright GL, Qu Y, Potter JD, Winget M, Thornquist M, Feng Z. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Biostatistics (Oxford, England). 4: 449-63. PMID 12925511 DOI: 10.1093/Biostatistics/4.3.449 |
0.337 |
|
| 2003 |
Qu Y, Adam BL, Thornquist M, Potter JD, Thompson ML, Yasui Y, Davis J, Schellhammer PF, Cazares L, Clements M, Wright GL, Feng Z. Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality data. Biometrics. 59: 143-51. PMID 12762451 DOI: 10.1111/1541-0420.00017 |
0.349 |
|
| 2003 |
Penson DF, Feng Z, Kuniyuki A, McClerran D, Albertsen PC, Deapen D, Gilliland F, Hoffman R, Stephenson RA, Potosky AL, Stanford JL. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 1147-54. PMID 12637483 DOI: 10.1200/Jco.2003.07.139 |
0.389 |
|
| 2002 |
Thompson B, Coronado GD, Solomon CC, McClerran DF, Neuhouser ML, Feng Z. Cancer prevention behaviors and socioeconomic status among Hispanics and non-Hispanic whites in a rural population in the United States. Cancer Causes & Control : Ccc. 13: 719-28. PMID 12420950 DOI: 10.1023/A:1020280427712 |
0.316 |
|
| 2002 |
Qu Y, Adam BL, Yasui Y, Ward MD, Cazares LH, Schellhammer PF, Feng Z, Semmes OJ, Wright GL. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clinical Chemistry. 48: 1835-43. PMID 12324514 |
0.303 |
|
| 2002 |
Qu Y, Adam BL, Yasui Y, Ward MD, Cazares LH, Schellhammer PF, Feng Z, Semmes OJ, Wright GL. Boosted Decision Tree Analysis of Surface-enhanced Laser Desorption/Ionization Mass Spectral Serum Profiles Discriminates Prostate Cancer from Noncancer Patients Clinical Chemistry. 48: 1835-1843. DOI: 10.1093/Clinchem/48.10.1835 |
0.391 |
|
| 2001 |
Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y. Phases of biomarker development for early detection of cancer. Journal of the National Cancer Institute. 93: 1054-61. PMID 11459866 DOI: 10.1093/Jnci/93.14.1054 |
0.347 |
|
| 2000 |
Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The prostate cancer outcomes study Journal of the American Medical Association. 283: 354-360. PMID 10647798 DOI: 10.1001/Jama.283.3.354 |
0.378 |
|
| 2000 |
Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. The American Journal of Gastroenterology. 95: 3089-3096. DOI: 10.1016/S0002-9270(00)01975-4 |
0.378 |
|
| 1995 |
Herrinton LJ, Weiss NS, Beresford SA, Stanford JL, Wolfla DM, Feng Z, Scott CR. Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer. American Journal of Epidemiology. 141: 407-16. PMID 7879785 DOI: 10.1093/Oxfordjournals.Aje.A117443 |
0.33 |
|
| Show low-probability matches. |